A Search For Biomarkers For Early Detection Of Colorectal Cancer

October 23, 2007 – 10:29 am | posted in Colorectal Cancer

Researchers at the Zhejiang University, Hangzhou have discovered that mimecan and Thioredoxin Domain-Containing Protein 5 (TXNDC5) were differentially expressed in colorectal adenoma. The research article describing this work entitled Differential Expression of Mimecan and Thioredoxin Domain-Containing Protein 5 in Colorectal Adenoma and Cancer: A Proteomic Study will be featured in Experimental Biology and Medicine. Adenoma is the major precursor lesion of colorectal cancer, one of the most common cancers worldwide. The elucidation of the molecular mechanism underlying adenoma is essential for early detection, prevention and intervention of colorectal cancer. The research team, led by Maode Lai, a professor of molecular pathology, f…

Also Read

  • Ovarian Cancer Biomarkers Are Sought To Enhance Early Disease Detection
  • Orion Genomics Announces The Discovery And Validation Of Novel Breast Cancer Biomarkers
  • Concerning The Colon And Cancer, Delaying Bad News Is Much Worse
  • Health Officials Urge Support For Screening For Colorectal Cancer
  • Statin Use Not Associated With Colorectal Cancer Risk
  • Fighting Colorectal Cancer
  • 88 Percent Sensitivity For Colon Cancer Reported Using Non-Invasive Screening Test
  • What are the signs. How can you tell?
  • Quality Care Assessment Examines Surgical Quality For Colorectal Cancer Patients
  • New Test For Early Stage Ovarian Cancer Is 99 Percent Accurate
  • You must be logged in to post a comment.